Valuation: Abbott Laboratories

Market Cap 16TCr 14TCr 13TCr 11TCr 22TCr 14,96500Cr 22TCr 1,49100Cr 59TCr 7,30800Cr 58TCr 57TCr 25,20100Cr P/E 2026 *
22.3x
P/E 2027 * 19.1x
Enterprise Value 17TCr 15TCr 13TCr 12TCr 23TCr 16,09000Cr 24TCr 1,60300Cr 63TCr 7,85700Cr 63TCr 61TCr 27,09600Cr EV / Sales 2026 *
3.33x
EV / Sales 2027 * 3x
Free-Float
86.73%
Yield 2026 *
2.85%
Yield 2027 * 3.04%
1 day-5.81%
1 week-5.81%
Current month-2.01%
1 month+0.69%
3 months-11.52%
6 months-27.00%
Current year-26.26%
1 week 73
Extreme 73
77.5
1 month 71
Extreme 71
77.5
Current year 65
Extreme 65
100
1 year 65
Extreme 65
106
3 years 65
Extreme 65
106
5 years 65
Extreme 65
128
10 years 34.75
Extreme 34.75
128
Manager TitleAgeSince
Chief Executive Officer 52 31/03/2020
Director of Finance/CFO 53 01/09/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 09/12/2011
Director/Board Member 67 09/12/2011
Director/Board Member 71 16/02/2017
Change 5-day change 1-year change 3-year change Capi.($)
-5.81%-5.81% - - 15TCr
+1.48%-4.01%-10.32%-8.19% 10TCr
-1.89%-2.60%-0.16%+54.93% 5.88TCr
-0.94%-1.23%+39.41%+54.08% 5.28TCr
+2.81%-0.91%-12.54%-40.29% 4.15TCr
+2.02%-8.30% - - 3.27TCr
-1.88%-1.14%-14.77%-47.04% 2.86TCr
+0.38%+0.82%+59.92%-6.78% 2.53TCr
+1.31%-1.82%-6.35%-7.69% 2.03TCr
+0.27%+5.41%-3.65%-17.97% 2.1TCr
Average +0.08%-1.88%+6.44%-2.37% 4.25TCr
Weighted average by Cap. -1.21%-2.64%+3.97%+4.38%

Financials

2026 *2027 *
Net sales 5.03TCr 4.38TCr 4.04TCr 3.71TCr 7.05TCr 4,83700Cr 7.17TCr 48TCr 19TCr 2,36200Cr 19TCr 18TCr 8,14600Cr 5.47TCr 4.77TCr 4.4TCr 4.04TCr 7.68TCr 5,26800Cr 7.81TCr 52TCr 21TCr 2,57300Cr 21TCr 20TCr 8,87200Cr
Net income 692.33Cr 603.65Cr 557.11Cr 511.26Cr 971.54Cr 67TCr 987.77Cr 6.64TCr 2.61TCr 33TCr 2.6TCr 2.54TCr 1,12200Cr 828.5Cr 722.38Cr 666.68Cr 611.81Cr 1.16TCr 80TCr 1.18TCr 7.94TCr 3.12TCr 39TCr 3.11TCr 3.04TCr 1,34300Cr
Net Debt 1.17TCr 1.02TCr 940.61Cr 863.19Cr 1.64TCr 1,12500Cr 1.67TCr 11TCr 4.4TCr 55TCr 4.39TCr 4.29TCr 1,89500Cr 884.06Cr 770.83Cr 711.39Cr 652.84Cr 1.24TCr 85TCr 1.26TCr 8.48TCr 3.33TCr 42TCr 3.32TCr 3.25TCr 1,43300Cr
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
1,15,000
Date Price Change
15/26/15 CHF 73.00 -5.81%
14/26/14 CHF 77.50 0.00%
13/26/13 CHF 77.50 0.00%
10/26/10 CHF 77.50 0.00%
09/26/09 CHF 77.50 0.00%
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
89.27USD
Average target price
116.40USD
Spread / Average Target
+30.39%

Quarterly revenue - Rate of surprise